These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. In vitro and clinical studies of the removal of cortisol, thyroxine, insulin, and thyroid-stimulating hormone by coated charcoal haemoperfusion. Dixit V; Chang TM Life Support Syst; 1984; 2(4):238-44. PubMed ID: 6396457 [TBL] [Abstract][Full Text] [Related]
43. Neutrophil adherence during hemoperfusion in fulminant hepatic failure. Altin M; Hughes RD; Williams R Int J Artif Organs; 1982 Sep; 5(5):315-7. PubMed ID: 7174138 [TBL] [Abstract][Full Text] [Related]
44. [Experience in using hemosorption in treating liver failure]. Skiba VV; Voĭtenko GH; Kolesnikov EB; Zubkov VI; Bondarevskaia TM Klin Med (Mosk); 1980 Apr; 58(4):87-90. PubMed ID: 7382374 [No Abstract] [Full Text] [Related]
45. Use of artificial liver support. Williams R; Ede R; Hughes R Int J Clin Pharmacol Res; 1985; 5(6):381-7. PubMed ID: 3005180 [TBL] [Abstract][Full Text] [Related]
46. Panel conference. Adsorbent hemoperfusion for blood purification. Chang TM; Winchester JF; Rosenbaum J; Saito A; Stefoni S; Shu C; Gurland HL Trans Am Soc Artif Intern Organs; 1980; 26():593-7. PubMed ID: 7245556 [No Abstract] [Full Text] [Related]
47. [Exchange transfusion and cross circulation with baboons in the treatment of acute liver failure]. Saunders SJ; Bosman SC; Barnard CN; Terblanche J Internist (Berl); 1970 Mar; 11(3):77-84. PubMed ID: 4995117 [No Abstract] [Full Text] [Related]
48. Fulminant hepatitis in a juvenile-onset diabetic. Course after recovery from hepatic failure treated with exchange transfusion. Goldstein LI; Lipitz L; Niosi P; Trey C Am J Gastroenterol; 1970 Apr; 53(4):352-9. PubMed ID: 5309613 [No Abstract] [Full Text] [Related]
49. New adsorbents in acute hepatic failure. Horak W Hepatogastroenterology; 1980 Aug; 27(4):251-3. PubMed ID: 7203361 [No Abstract] [Full Text] [Related]
50. Efficacy and limitations of plasma exchange in patients with acute hepatic failure; comparing with hemoadsorption, and with impaired regeneration syndrome. Soeda K; Odaka M; Tabata Y; Kobayashi S; Itoh Y; Isono K Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):203-11. PubMed ID: 1751671 [No Abstract] [Full Text] [Related]
52. Review of support systems used in the management of fulminant hepatic failure. McGuire BM; Sielaff TD; Nyberg SL; Hu MY; Cerra FB; Bloomer JR Dig Dis; 1995; 13(6):379-88. PubMed ID: 8590524 [TBL] [Abstract][Full Text] [Related]
53. [Liver substitution and liver grafting (author's transl)]. Pichlmayr R; Bockhorn H; Bunzendahl H MMW Munch Med Wochenschr; 1978 Feb; 120(7):207-10. PubMed ID: 342926 [TBL] [Abstract][Full Text] [Related]
54. [New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals]. Omori Y Nihon Geka Gakkai Zasshi; 1985 May; 86(5):566-75. PubMed ID: 4021990 [TBL] [Abstract][Full Text] [Related]
55. Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient. Chang TM; Espinosa-Meléndez E; Francoeur TE; Eade NR Pediatrics; 1980 Apr; 65(4):811-4. PubMed ID: 7367091 [TBL] [Abstract][Full Text] [Related]